New FDA-Approved Treatment for RKD

The FDA has approved Ultomiris for adults with IgA Nephropathy (IgAN). More information coming soon. Please visit our Patient Navigation tool for support.

RESOURCES

/

FIND A SPECIALIST

/

CONTACT

Alondra Vasquez

Manager, Patient Engagement

Alondra Vasquez joined the NephCure team in May 2026 and serves as the Patient Engagement Manager. Alondra brings years of experience in volunteer program management, youth development, with a strong focus on community engagement. Most recently, she led the development and implementation of an organization wide volunteer program aimed at reducing social isolation experienced by older adults in the Bronx. Alondra’s passion for community-driven programs stems from dedicating a year of service through AmeriCorps Civic Corps program in New York City at South Bronx United, a youth development organization that uses soccer as a vehicle for social change, where she spent several years after supporting youth and strengthening community connections. 

Alondra is a proud Bronx native that enjoys spending time with family, exploring New York City, and staying active through fitness and running.

New York, NY

Related News

NEWS

The FDA Grants Accelerated Approval of ULTOMIRIS (ravulizumab-cwvz) for Adults with IgA Nephropathy 

NEWS

NephCure Applauds U.S. Department of Health and Human Services on the Release of the Rare Kidney Disease Inclusive Kidney Care National Plan

NEWS

NephCure Celebrates C3G Awareness Day on September 25, 2026

NEWS

NephCure Specialist of the Month: Dr. Rupali Avasare

Sign up to get NephCure’s latest updates.

SIGN UP
This field is for validation purposes and should be left unchanged.